[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Insider transactions at Clorox Co (CLX): an executive reported multiple equity transactions on 10/03/2025. The reporting person acquired 8,672 shares through settlement of a 2022 performance unit grant at an effective price of $122.25, increasing direct holdings to 35,667 shares. The filing also shows withholding of 1,904 and 3,629 shares to satisfy tax obligations tied to restricted stock and performance stock units, respectively, and 462 shares from dividend reinvestment. Additionally, 612.574 shares are held indirectly via the company 401(k). The form was signed by an attorney-in-fact on 10/07/2025.

Positive

• Settlement of performance units increased direct ownership by 8,672 shares
• Post-transaction direct holdings are 35,667 shares, showing continued executive stake

Negative

• Significant share withholding for taxes (1,904 and 3,629 shares) reduced net share additions
• Majority of acquired shares were from vesting rather than open‑market purchases, limiting positive market signaling

Insights

Compensation Analyst

Settlement of long‑term incentive increased exec ownership without open‑market buying.

The 2022 performance unit grant vested and settled on 10/03/2025, delivering 8,672 shares at an effective value of $122.25 per share. This is a routine compensation event converting deferred equity into stock, raising direct holdings to 35,667 shares.

Withholding of 1,904 and 3,629 shares to cover taxes reduced net share additions; 10/03/2025 activity therefore shows compensation realization rather than discretionary open‑market purchases. Monitor next proxy for updated executive ownership and potential future grants within the next fiscal year.

Corporate Governance Analyst

Insider holdings rose modestly; indirect holdings via benefits plan remain small.

Post‑transaction direct ownership is reported as 35,667 shares, with 612.574 shares held indirectly through the company 401(k). The mix of settlement and tax withholding is typical and does not indicate trading for liquidity or signaling.

Investors may note the form was executed by an attorney‑in‑fact on 10/07/2025. Watch upcoming filings for any scheduled sales or additional vesting dates tied to long‑term incentive schedules.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hilt Angela C

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Chief Legal Officer

3. Date of Earliest Transaction (Month/Day/Year)
10/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/03/2025		A(1)		8,672	A	$122.25	35,667	D
Common Stock	10/03/2025		F(2)		1,904	D	$122.25	33,763	D
Common Stock	10/03/2025		F(3)		3,629	D	$122.25	30,134(4)	D
Common Stock								612.574(5)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Settlement of 2022 Performance Unit Grant, which vested 10/3/25.

2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.

3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.

4. Includes 462 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.

5. Includes shares acquired through 10/3/25, pursuant to the Company's 401(k) plan.

	By Jinho Joo, Attorney-in-Fact	10/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did CLX insider report on Form 4 dated 10/03/2025?

The reporting person had a 2022 performance unit grant settle for 8,672 shares and had 1,904 and 3,629 shares withheld for tax related to restricted stock and performance units.

How many CLX shares does the reporting person own after the 10/03/2025 transactions?

The filing reports 35,667 shares owned directly after the transactions, plus 612.574 shares indirectly via a 401(k).

At what price were the shares reported on the CLX Form 4 transaction?

The effective price tied to the settlement is listed as $122.25 per share.

Why were shares withheld in the CLX insider filing?

The filing explains shares were withheld by the company to satisfy tax obligations related to vesting of restricted stock and performance stock units.

Who signed the CLX Form 4 and when was it filed?

The form was signed by an attorney‑in‑fact, Jinho Joo, and dated 10/07/2025.